Edythe D London

Title: Edythe D London: Innovator in Radiolabeled Compounds

Introduction

Edythe D London is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of radiolabeled compounds, particularly in the study of nicotinic cholinergic receptors. With a total of 4 patents, her work has implications for both research and clinical applications.

Latest Patents

Edythe's latest patents include innovative methods for imaging nicotinic acetylcholinergic receptors in the brain. One of her notable inventions is directed to radiolabeled pyridyl-7-azabicyclo[2,2,1]heptanes. This invention focuses on radiolabeled epibatidine analogues, specifically FPH labeled with radioisotopes of fluorine and/or carbon. These compounds are utilized to noninvasively image and quantify nicotinic cholinergic receptors in the living brain, aiding in research studies and the diagnosis of neurodegenerative diseases.

Career Highlights

Throughout her career, Edythe has worked with the United States of America as represented by the Department of Health. Her expertise in radiolabeled compounds has positioned her as a key figure in her field.

Collaborations

Edythe has collaborated with notable individuals such as Alane S Kimes and Andrew Horti. These partnerships have contributed to her innovative work and advancements in the study of brain receptors.

Conclusion

Edythe D London is a trailblazer in the field of radiolabeled compounds, with a focus on imaging techniques that enhance our understanding of neurodegenerative diseases. Her contributions continue to impact both research and clinical practices.